Organisation paid for research Program year 2022 Source: CMS Open Payments

Abraham Research, PLLC

Neither a doctor nor a teaching hospital

Research payments

$111,684

52 payments

Through program year 2022, Abraham Research, PLLC is reported as receiving $111,684 in research payments, across 52 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$83	1
2021	Research	$5,817	2
2020	Research	$11,413	9
2019	Research	$94,370	40

Breakdown

Who paid Research payments · program years 2019–2022

Merck Sharp & Dohme Corporation $111,349 41 payments
Cipla USA Inc. $335 11 payments

Studies the money was for Research payments · program years 2019–2022

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-MonthStudy to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with ChronicCough PN030 $92,558 26 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with Chronic Cough PN030 $16,866 6 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-MonthStudy to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with ChronicCough PN030 $1,477 3 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of MK-7264 in Adult Participants with Chronic Cough PN030 $361 4 payments
U-Fs-Mu-As3120 $335 11 payments
A Phase III, Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed Ambrosia artemisiifolia Sublingual Immunotherapy Tablet, in Children With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma $86 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.